Otsuka's tolvaptan approved in Japan

Scrip   

Otsuka's tolvaptan approved in Japan
October 28, 2010

Ian Haydock

ian.haydock@informa.com

Japan's ministry of health, labour and welfare has issued a formal final approval for the use of Otsuka Pharmaceutical's vasopressin V2-receptor antagonist diuretic, Samsca (tolvaptan), in patients with congestive heart failure (CHF).